Search Results

Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance (HBV IMDR)

• Authors : Hong You, Chief Physician

• Source: Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance

Record details

Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.

• Source: Presence of HIV-1 DRMs As a Risk Factor of Failure of Two Drugs Based ART Regimens, Including LAI ART, in Cohorts of Primary and Secondary DRMs.Rhee SY, Kassaye SG, Barrow G, Sundaramurthi JC,

Record details

Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)

• Authors : Mao-Lin Yan, Principal Investigator

• Source: Safety and Efficacy of Fecal Microbiota Transplantation in Reversing Drug Resistance in Patients With Intermediate-advanced Unresectable

Record details

Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial (3ACT)

• Authors : The Swedish Research Council; Uppsala University; Billy Ngasala, Associate Professor

• Source: Can Triple Artemisinin-based Combination Therapy for Treatment of Uncomplicated Plasmodium Falciparum Malaria, Delay Drug Resistance

Record details

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance

• Source: Collection of Blood, Fluid, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer or Normal Volunteers

Record details

Tuberculosis Research of INA-RESPOND On Drug Resistance (TRIPOD)

• Authors : National Institute of Health Research and Development, Ministry of Health Republic of Indonesia; National Institute of Allergy and Infectious Diseases (NIAID)

• Source: Tuberculosis Research of INA-RESPOND On Drug ResistanceZifodya JS, Kreniske JS, Schiller I, Kohli M, Dendukuri N, Schumacher SG,

Record details

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

• Authors : Xiaomin Niu, Principal Investigator

• Source: Molecular Landscape of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients With Chinese Advanced Non-small Cell Lung CancerSamstein RM, Lee

Record details

HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based Regimen (DTG-Resist)

• Authors : University of Zurich; ETH Zurich; University of KwaZulu

• Source: HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir-based 1st, 2nd or 3rd Line Regimens: the International

Record details

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

• Authors : Karyopharm Therapeutics Inc; Patrick Stiff, Senior Professor

• Source: Combination of the Hypomethylating Agent Decitabine and the Nuclear Export Receptor XPO-1 Inhibitor Selinexor to Reverse Platinum Resistance in Relapsed/Refractory

Record details

Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma (TEDROMM)

• Authors : Campus Bio-Medico University; University of Rome Tor Vergata; Sant'Eugenio Hospital, Rome

• Source: Transcriptomics and Epigenetics Analysis for Biomarkers Identification Involved in Drug-resistance Mechanisms of Multiple Myeloma

Record details